Business
MASCC Conference
MASCC Conference.
About this update from Genedrive Plc
[{"type":"text","content":"\n RNS Number : 1709X EpiStem Holdings plc 23 June 2008 \n\nFor release: 23rd June 2008\n\nEPISTEM SHOWCASE NIH DATA AT MASCC CONFERENCE IN HOUSTON\n\nEpistem plc (LSE: EHP), the UK biotechnology company announced today that details of its US National Institute of Health's (NIH) programme for the screening of a number of novel agents, including potential oncology supportive care treatments, for biodefence applications will be presented at the Multinational Association of Supportive Care in Cancer (MASCC) International Symposium of Supportive Care in Houston, Texas, USA from 26th to 28th June 2008.\n\nEpistem's Contract Research division provides scientific expertise and preclinical research models to the NIH's research programme on Medical Countermeasures Against Radiological and Nuclear Threats (MCART). This research programme, funded by the National Institute of Allergy and Infectious Diseases through a contract with the University of Maryland School of Medicine, tests drugs from early screening through advanced development for the prevention and treatment of radiation sickness following exposure to high dose radiation following a nuclear terrorist attack. \n\nEpistem has developed its proprietary models to provide a unique insight into the mechanisms of intestinal damage and repair following radiation exposure. Epistem's models evaluate the efficacy, mechanism of action, optimal drug dosing and scheduling of potential new treatments. The company has previously developed similar preclinical models for use in anti- mucositis, inflammatory bowel disease and wound healing drug screening. These models are now widely used by a range of pharmaceutical and biotechnology companies. \n\nThe presentation will demonstrate the screening conditions that have been defined and in which drugs must demonstrate efficacy prior to further investment and development by MCART. An abstract can be viewed under 'latest news' on the Epistem website at www.epistem.co.uk .\n\n\n \nFor further information, please contact:\n\nMatthew Walls +44 (0)161 606 7258\nChief Execu...